| Views | |
|---|---|
| Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 263 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 3 | 3 | 16 | 7 | 10 | 13 | 2 |
| Views | |
|---|---|
| 2021_Correll_etal.pdf | 7514 |
